Detalles de la búsqueda
1.
PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors.
BMC Urol
; 24(1): 96, 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38658905
2.
The multispeciality approach to the management of localised kidney cancer.
Lancet
; 400(10351): 523-534, 2022 08 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35868329
3.
Impact of COVID-19 on the management and outcomes of ureteric stones in the UK: a multicentre retrospective study.
BJU Int
; 131(1): 82-89, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36083711
4.
Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group.
World J Urol
; 41(4): 929-940, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35362747
5.
Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder.
Exp Mol Pathol
; 131: 104860, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36997051
6.
Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumors.
Acta Oncol
; 62(12): 1880-1889, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37938166
7.
Risk models for recurrence and survival after kidney cancer: a systematic review.
BJU Int
; 130(5): 562-579, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34914159
8.
Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC.
World J Urol
; 40(3): 739-746, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34859284
9.
Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration.
World J Urol
; 40(5): 1167-1174, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35218372
10.
Intermediate- and long-term oncological outcomes of active surveillance for localized renal masses: a systematic review and quantitative analysis.
BJU Int
; 128(2): 131-143, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34060192
11.
Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
BJU Int
; 128(3): 386-394, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33794055
12.
Outcome after resection of occult and non-occult lymph node metastases at the time of nephrectomy.
World J Urol
; 39(9): 3377-3383, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33634323
13.
Clinical, surgical, pathological and follow-up features of kidney cancer patients with Von Hippel-Lindau syndrome: novel insights from a large consortium.
World J Urol
; 39(8): 2969-2975, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33416974
14.
Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinoma.
World J Urol
; 39(10): 3823-3831, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33851271
15.
Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy.
Nature
; 521(7550): 94-8, 2015 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25924065
16.
Impact of Resection Technique on Perioperative Outcomes and Surgical Margins after Partial Nephrectomy for Localized Renal Masses: A Prospective Multicenter Study.
J Urol
; 203(3): 496-504, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31609167
17.
Chest computed tomography for staging renal tumours: validation and simplification of a risk prediction model from a large contemporary retrospective cohort.
BJU Int
; 125(4): 561-567, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31955483
18.
Evaluation of the prognostic role of co-morbidities on disease outcome in renal cell carcinoma patients.
World J Urol
; 38(6): 1525-1533, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31520111
19.
External validation of a postoperative nomogram for the prediction of disease-specific survival in patients with papillary renal cell carcinoma using a large multicenter database.
Int J Clin Oncol
; 25(1): 145-150, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31471787
20.
The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort.
BMC Med
; 17(1): 182, 2019 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31578141